Atrys Health, S.A. (BME:ATRY)

Spain · Delayed Price · Currency is EUR

2.960

-0.060 (-1.99%)

At close: Feb 26, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Precision Oncology	63.49M	58.03M	35.42M	-	-
Precision Oncology Growth	9.41%	63.84%	-	-	-
Medicine Prevention	83.22M	79.70M	74.05M	44.92M	-
Medicine Prevention Growth	4.42%	7.64%	64.84%	-	-
Diagnostic Medicine	71.39M	68.37M	53.74M	-	-
Diagnostic Medicine Growth	4.41%	27.23%	-	-	-
Medicine Precision	-	-	-	62.85M	31.40M
Medicine Precision Growth	-	-	-	100.19%	-
Compliance Service	-	-	-	13.24M	-
Total	218.10M	206.10M	163.20M	121.01M	31.40M
Total Growth	5.82%	26.28%	34.86%	285.44%	111.61%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Spain	156.18M	150.18M	117.90M	81.47M	22.33M
Spain Growth	4.00%	27.38%	44.72%	264.86%	80.71%
Portugal	15.02M	14.17M	13.85M	11.83M	-
Portugal Growth	5.96%	2.33%	17.05%	-	-
Latin America	41.55M	37.22M	26.62M	24.54M	9.07M
Latin America Growth	11.63%	39.82%	8.49%	170.61%	265.51%
Switzerland	-	-	-	3.18M	-
Total	212.74M	201.57M	158.37M	121.01M	31.40M
Total Growth	5.54%	27.28%	30.87%	285.44%	111.61%

Source: S&P Global Market Intelligence.